MORGAN STANLEY - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 35 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$17,000
-41.4%
8,377
-42.1%
0.00%
Q2 2014$29,000
-9.4%
14,477
+38.2%
0.00%
Q1 2014$32,000
-28.9%
10,477
-23.0%
0.00%
Q4 2013$45,000
-75.9%
13,601
-76.9%
0.00%
Q3 2013$187,000
+103.3%
58,898
+93.0%
0.00%
Q2 2013$92,00030,5120.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,031,874$6,258,0006.29%
NEA Management Company, LLC 2,086,755$6,427,0000.32%
BVF INC/IL 150,000$462,0000.07%
Central Square Management LLC 19,000$59,0000.06%
ABNER HERRMAN & BROCK LLC 20,000$62,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 137,000$422,0000.01%
SHEPHERD KAPLAN KROCHUK, LLC 31,000$95,0000.01%
Spark Investment Management LLC 11,100$34,0000.01%
Waverly Advisors, LLC 2,670$8,0000.00%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 33,384$103,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders